Phathom Pharmaceuticals, Inc. PHAT Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s interest paid?
- Phathom Pharmaceuticals, Inc. (PHAT) reported interest paid of $4.94M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s interest paid changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s interest paid decreased by 5.5% year-over-year, from $5.23M to $4.94M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s interest paid has grown at a 51.4% compound annual growth rate (CAGR), from $4.07M to $21.37M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.